Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Phase 3 results showed approximately 15-17% body weight reduction over 48 weeks, positioning it competitively with tirzepatide
Shipping is the vulnerable point
Nat Commun 8 (1), 1177 (2017)
Darsalia V, Ortster H, Olverling A, Darlf E, Wolbert P, Nystrm T, et al
For individuals with underlying health conditions such as type 2 diabetes mellitus or obesity, inadequate dosing could increase the risk of long-term complications such as uncontrolled diabetes, kidney diseases, and cardiovascular diseases associated with type 2 diabetes and obesity
US$ 27.32
US$ 26.33
US$ 23.86
US$ 21.97
US$ 26.50
US$ 20.67
US$ 25.73
US$ 25.43
US$ 24.24
US$ 26.12
US$ 24.18
